Regulatory noncoding RNAs: potential biomarkers and therapeutic targets in acute myeloid leukemia

xlomafota13 shared this article with you from Inoreader Regulatory noncoding RNAs: potential biomarkers and therapeutic targets in acute myeloid leukemia Via American Journal of Blood Research Am J Blood Res. 2021 Oct 15;11(5):504-519. eCollection 2021. ABSTRACT The noncoding RNAs (ncRNA) comprise a substantial segment of the human transcriptome and have emerged as key elements of cellular homeostasis and disease pathogenesis. Dysregulation of these ncRNAs by alterations in the primary RNA motifs and/or aberrant expression levels is relevant in various diseases, especially cancer. The recent research advances indicate that ncRNAs regulate vital oncogenic processes, including hematopoietic cell differentiation, proliferation, apoptosis, migration, and angiogenesis. The ever-expanding role of ncRNAs in cancer progression and metastasis has sparked interest as potential diagnostic and prognostic biomarkers in acute myeloid leukemia. Moreover, advances in antisense oligonucleotide technologies and pharmacologic discoveries of small molecule inhibitors in targeting RNA structures and RNA-protein complexes have opened newer avenue s that may help develop the next generation anti-cancer therapeutics. In this review, we have discussed the role of ncRNA in acute myeloid leukemia and their utility as potential biomarkers and therapeutic targets. PMID:34824883 | PMC:PMC8610797 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.